nicotine has been researched along with topiramate in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (60.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Alexoff, DL; Barnett, C; Dewey, SL; Geiger, J; Gerasimov, MR; Marsteller, DA; Schiffer, WK | 1 |
| Johnson, BA | 1 |
| Kosten, T; Mouratidis, M; Poling, J; Sofuoglu, M | 1 |
| Flammino, F; Palamar, J; Raghavan, S; Reid, MS | 1 |
| Ait-Daoud, N; Breland, AB; Johnson, BA; Lynch, WJ; Marzani-Nissen, GR; Penberthy, JK | 1 |
| Barnes, C; Goldberg, SR; Justinova, Z; Le Foll, B; Wertheim, CE | 1 |
| Alda, M; Andrés, E; Crucelaegui, A; García Campayo, J; Magallón, R; Mas, A; Sanz, B; Sobradiel, N | 1 |
| Chakrabarti, A; Medhi, B; Sahai, AK; Sood, N | 1 |
| Chakrabarti, A; Hota, D; Sahai, AK; Sood, N | 1 |
| Gillman, AG; Kosobud, AE; Leffel, JK; Timberlake, W | 1 |
| Goutier, W; Kloeze, M; McCreary, AC | 1 |
2 review(s) available for nicotine and topiramate
| Article | Year |
|---|---|
Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence?
Topics: Alcoholism; Anticonvulsants; Brain; Ethanol; Fructose; Humans; Nicotine; Tobacco Use Disorder; Topiramate | 2004 |
Treating smoking dependence in depressed alcoholics.
Topics: Alcoholism; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder; Fructose; Humans; Nicotine; Psychotherapy, Group; Smoking Cessation; Topiramate | 2006 |
3 trial(s) available for nicotine and topiramate
| Article | Year |
|---|---|
Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers.
Topics: Administration, Oral; Adult; Arousal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fructose; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Neuropsychological Tests; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Topiramate | 2006 |
Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers.
Topics: Adult; Behavior, Addictive; Blood Pressure; Cues; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fructose; Ganglionic Stimulants; Heart Rate; Humans; Male; Middle Aged; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Topiramate | 2007 |
Effectiveness of topiramate for tobacco dependence in patients with depression; a randomised, controlled trial.
Topics: Adolescent; Adult; Aged; Depressive Disorder, Major; Female; Follow-Up Studies; Fructose; Humans; Male; Middle Aged; Neuroprotective Agents; Nicotine; Psychotherapy; Smoking Cessation; Tobacco Use Disorder; Topiramate | 2008 |
10 other study(ies) available for nicotine and topiramate
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Topiramate selectively attenuates nicotine-induced increases in monoamine release.
Topics: Animals; Anticonvulsants; Biogenic Monoamines; Brain Chemistry; Dopamine; Drug Interactions; Fructose; Microdialysis; Nicotine; Nicotinic Agonists; Norepinephrine; Serotonin; Topiramate | 2001 |
Topiramate does not alter nicotine or cocaine discrimination in rats.
Topics: Animals; Anticonvulsants; Cocaine; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fructose; Injections, Intraperitoneal; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Topiramate | 2008 |
Dose-finding study with nicotine as a proconvulsant agent in PTZ-induced seizure model in mice.
Topics: Animals; Anticonvulsants; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Fructose; Ganglionic Stimulants; Male; Mice; Nicotine; Pentylenetetrazole; Seizures; Topiramate; Valproic Acid | 2008 |
Nicotine reversal of anticonvulsant action of topiramate in kainic acid-induced seizure model in mice.
Topics: Animals; Anticonvulsants; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Agonists; Fructose; Humans; Kainic Acid; Lipid Peroxidation; Male; Mecamylamine; Mice; Nicotine; Nicotinic Antagonists; Receptors, Nicotinic; Seizures; Topiramate | 2011 |
Behavioral characteristics and pharmacological manipulations of a nicotine-entrainable circadian oscillator.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Behavior, Animal; Benzoxazoles; Circadian Rhythm; Feeding Behavior; Female; Fructose; Light; Motor Activity; Naltrexone; Naphthyridines; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Oscillometry; Rats; Rats, Sprague-Dawley; Time Factors; Topiramate; Urea | 2013 |
Nicotine-induced locomotor sensitization: pharmacological analyses with candidate smoking cessation aids.
Topics: Acamprosate; Analysis of Variance; Animals; Antidiuretic Hormone Receptor Antagonists; Bupropion; Dose-Response Relationship, Drug; Fructose; Indoles; Male; Motor Activity; Naltrexone; Nicotine; Nicotinic Agonists; Pyrrolidines; Rats, Wistar; Taurine; Tobacco Use Cessation Devices; Topiramate | 2016 |